Reply to comment on ''Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders''

By Smeland S.   Muller C.   Saeter G.  

European Journal of Cancer, Vol. 39, Iss. 17, 2003-11 ,pp. : 2567-2568

Elsevier

Access to resources Recommend Favorite

Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII - prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders

By Smeland S.   Muller C.   Alvegard T.A.   Wiklund T.   Wiebe T.   Bjork O.   Stenwig A.E.   Willen H.   Holmstrom T.   Folleras G.   Brosjo O.   Kivioja A.   Jonsson K.   Monge O.   Saeter G.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 488-494

Elsevier

Access to resources Recommend Favorite

Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol

By Elomaa I.   Blomqvist C.P.   Saeter G.   &   9kerman M.   Stenwig E.   Wiebe T.   Bjork O.   Alvegard T.A.  

European Journal of Cancer, Vol. 36, Iss. 7, 2000-05 ,pp. : 875-880

Elsevier

Access to resources Recommend Favorite

The outcome of advanced soft tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian sarcoma group experience

By Wiklund T.   Saeter G.   Strander H.   Alvegard T.   Blomqvist C.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 357-361

Elsevier

Access to resources Recommend Favorite

Predictive Factors of Histological Response to Primary Chemotherapy in Ewing's Sarcoma

By Bacci Gaetano   Picci Piero   Mercuri Mario   Ferrari Stefano   Longhi Alessandra   Cesari Marilena   Rosito Pasquale   Mancini Antonia F.   Barbieri Enza   Baldini Nicola  

Acta Oncologica, Vol. 37, Iss. 7-8, 1998-12 ,pp. : 671-676

Informa Healthcare

Access to resources Recommend Favorite